影响TPF方案治疗下咽癌患者疗效的临床因素分析

李连贺; 谭福宪; 岳文慧; 王红梅; 王洪敏; 薛浩; 温振雷

doi:10.13201/j.issn.1001-1781.2015.19.010

影响TPF方案治疗下咽癌患者疗效的临床因素分析

- 朝阳市中心医院耳鼻咽喉科(辽宁朝阳, 122000)

详细信息

通讯作者: 李连贺,E-mail:llh186@163.com

中图分类号: R739.65

收稿日期: 2015-06-11

Analysis of clinical factors for the efficacy of TPF in treating hypopharyngeal carcinoma

- Department of Otolaryngology, the Central Hospital of Chaoyang City, Chaoyang, 122000, China

More Information

Corresponding author: LI Lianhe, E-mail: llh186@163.com

Received Date: 11 June 2015

摘要

摘要: 目的: 应用TPF方案治疗下咽癌患者,探讨影响疗效的各种临床因素。方法: 回顾性分析20例接受TPF方案治疗的下咽癌患者,化疗2个疗程后根据影像学评估疗效制定下一步治疗方案,并对临床分型、肿瘤生长方式、病理类型、肿瘤分期、淋巴结转移及年龄等临床资料进行总结,分析可能影响疗效的临床因素。结果: ①20例下咽癌患者经TPF方案治疗2个疗程后客观缓解率为65%。②在下咽癌患者中,TPF方案的疗效与临床分型、肿瘤生长方式、病理类型有显著相关;与肿瘤分期、淋巴结转移及年龄差异无统计学意义。结论: 根据下咽癌临床分型、肿瘤生长方式、病理类型等临床因素,可以评估下咽癌对化疗的敏感性,为提出个体化治疗方案提供重要依据。
- 下咽肿瘤 /
- 化疗 /
- 个体化治疗
Abstract: Objective: To summarize the clinical effect of TPF regimen in the treatment of hypopharyngeal carcinoma and explore various clinical factors affecting treatment efficacy.Method: The clinical data of 20 cases with hypopharyngeal carcinoma, who received TPF treatment, were analyzed retrospectively. After two courses of chemotherapy, based on radiographic outcomes, next treatment plan was developed. To sum up the clinical information, including the clinical type, patterns of tumor growth, pathologic type, tumor stage, lymph node metastasis, age and so on. To analyze possible influencing factors affecting curative effect.Result: ①After 20 cases with hypopharyngeal carcinoma received two courses of TPF treatment, the effect was evaluated. Objective response rate was 65%. ②In patients with hypopharyngeal carcinoma, the efficacy of TPF therapy was significantly related to the clinical type, patterns of tumor growth and pathologic type; there was no statistical significance in tumor stage, lymph node metastasis and age.Conclusion: According to the clinical type, patterns of tumor growth and pathologic type of hypopharyngeal carcinoma, resistance to chemotherapy in hypopharyngeal carcinoma can be assessed, which provides important basis for designing individualized treatment plan.
- hypopharyngeal neoplasms /
- chemotherapy /
- individual treatment

HTML全文

参考文献(5)

[1]	HUANG W Y, JEN Y M, CHEN C M,et al.Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer[J].Radiat Oncol,2010,15:37-45.
[2]	LINDFORD A, MCINTYRE B, MARSH R,et al.Outcomes of the treatment of head and neck sarcomas in a tertiary referral center[J].Front Surg,2015,19:19-19.
[3]	VOUREXAKIS Z,LE RIDANT A M,DULG-UEROV P, et al. Pyriform sinus squamous cell carcinoma:oncological outcomes in good responders of induction chemotherapy based larynx preservation protocols[J].Eur Arch Otorhinolaryngol,2015,272:1725-1731.
[4]	FORASTIERE A A, ADELSTEIN D J, MANOLA J, et al.Induction chemotherapy meta-analysis in head and neck cancer:right answer, wrong question[J]. Clin Oncol, 2013,31:2844-2846.
[5]	VOUREXAKIS Z, JANOT F, DULGUEROV P, et al.Larynx preservation protocols:long-term functional outcomes in good responders to induction chemotherapy for pyriform sinus carcinoma[J]. ORL J Otorhinolaryngol Relat Spec, 2014,76:165-170.